Wockhardt’s US-based arm -- Wockhardt USA Inc -- has recalled 11,18,400 Metoprolol Succinate extended-release tablets, a hypertension drug, for ‘failed dissolution specifications’. The tablets have been manufactured by Mumbai-based Wockhardt and distributed by Wockhardt USA LLC.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
